Target intelligence / Profile preview

Melanoma antigen family E, 1 pseudogene (MAGEE1 pseudogene)

Target
MAGEE1 pseudogene
Molecular classification
Other (Pseudogene)
01

Overview

The Melanoma antigen family E, 1 pseudogene (ENSG00000277516), also referred to as MAGEE1 pseudogene, is annotated as a pseudogene and does not encode a functional protein product[1]. Pseudogenes are generally considered nonfunctional genomic elements, often lacking transcription or not producing a functional protein, and as such are not therapeutic targets, have no known biological function, known disease involvement, biomarkers, or relevant drug interactions. The presence of “pseudogene” in the name explicitly indicates its noncoding, nonfunctional character in a protein-coding or therapeutic context[1]. Key points: - This entry is a pseudogene and therefore not a viable drug target, nor is it associated with canonical molecular or disease functions. - If you are seeking information on a functional MAGE family E member, such as MAGEE1 (without the pseudogene suffix), please clarify, as this pseudogene should not be conflated with functional gene products[1]. - No disease roles, therapeutic interactions, or relevant functional data exist for pseudogenes such as this one. If your intent was to inquire about a functional MAGEE family member, such as MAGEE1, you should consult the entry for that specific protein-coding gene.

Other names
MAGEE1 pseudogeneMelanoma antigen, family E, 1Cancer/testis specific (MAGEE1) pseudogene

Beyond the preview

Go deeper on Melanoma antigen family E, 1 pseudogene (MAGEE1 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanoma antigen family E, 1 pseudogene (MAGEE1 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call